These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1836346)

  • 21. [Modern aspects of antiemetic therapy].
    Aleksandrović J; Dagović A; Jeremić B
    Srp Arh Celok Lek; 1998; 126(7-8):295-303. PubMed ID: 9863398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recent advances in the management of chemotherapy-induced emesis].
    Murakami M; Ota K
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):401-11. PubMed ID: 3006594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres.
    O'Brien BJ; Rusthoven J; Rocchi A; Latreille J; Fine S; Vandenberg T; Laberge F
    CMAJ; 1993 Aug; 149(3):296-302. PubMed ID: 8339175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Closing the gap in prophylactic antiemetic therapy: patient factors in calculating the emetogenic potential of chemotherapy.
    Doherty KM
    Clin J Oncol Nurs; 1999 Jul; 3(3):113-9. PubMed ID: 10690042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
    Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
    Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.
    Mahesh R; Perumal RV; Pandi PV
    Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of a new antiemetic, alizapride, in cancerology (author's transl)].
    Cupissol D; Favier F; Favier C; Serrou B
    Sem Hop; 1982 Jun; 58(22):1370-3. PubMed ID: 6287597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survey of antiemetic use in children with cancer.
    van Hoff J; Hockenberry-Eaton MJ; Patterson K; Hutter JJ
    Am J Dis Child; 1991 Jul; 145(7):773-8. PubMed ID: 2058609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of diazepam on delayed nausea and vomiting caused by anticancer agents].
    Tong FZ; Zhang JQ; Qiao XM; Mao YC; Meng FY; Liu HJ; Hui S; Zhu FX; Shu W; Hong J
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):391-5. PubMed ID: 9492833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Casopitant: a new warrior in the antiemetic crusade.
    Khojasteh A; Khojasteh A; Thornburg BG; Maher KR
    Expert Opin Pharmacother; 2009 Jun; 10(8):1367-76. PubMed ID: 19445564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New aspects in the prevention and therapy of cytostatic drug-induced nausea and vomiting].
    Evers C; Riess H
    Z Arztl Fortbild (Jena); 1992 Sep; 86(17):847-53. PubMed ID: 1413901
    [No Abstract]   [Full Text] [Related]  

  • 34. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
    de Wit R; Aapro M; Blower PR
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy-induced nausea and vomiting: state of the art in 2006.
    Schwartzberg L
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):3-8. PubMed ID: 16499138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of chemotherapy-induced nausea and emesis.
    Maule WF; Perry MC
    Am Fam Physician; 1983 Jan; 27(1):226-34. PubMed ID: 6130699
    [No Abstract]   [Full Text] [Related]  

  • 37. 5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?
    Aapro M; Blower P
    Cancer; 2005 Jul; 104(1):1-18. PubMed ID: 15929119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marijuana as an antiemetic drug: how useful is it today? Opinions from clinical oncologists.
    Schwartz RH; Beveridge RA
    J Addict Dis; 1994; 13(1):53-65. PubMed ID: 7503819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination antiemetic therapy in the control of chemotherapy-induced emesis.
    Fortner CL; Finley RS; Grove WR
    Drug Intell Clin Pharm; 1985 Jan; 19(1):21-4. PubMed ID: 3967569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin antagonists: treatment of chemotherapy-induced emesis.
    Barisano A; Mehl B; Bradbury K
    Mt Sinai J Med; 1992 Oct; 59(5):433-7. PubMed ID: 1435844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.